Cargando…

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors

QSAR modelling on Thirty (34) novel quinazoline derivatives (EGFR(WT) inhibitors) as non-small cell lung cancer (NSCLC) agents was performed to develop a model with good predictive power that can predict the activities of newly designed compounds that have not been synthesised. The EGFR(WT) inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Muhammad Tukur, Uzairu, Adamu, Uba, Sani, Shallangwa, Gideon Adamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013192/ https://www.ncbi.nlm.nih.gov/pubmed/32072038 http://dx.doi.org/10.1016/j.heliyon.2020.e03289

Ejemplares similares

In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents
por: Ibrahim, Muhammad Tukur, et al.
Publicado: (2020)

Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents
por: Abdullahi, Sagiru Hamza, et al.
Publicado: (2023)

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents
por: Olasupo, Sabitu Babatunde, et al.
Publicado: (2020)

Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

QSAR analysis and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents
por: Olasupo, Sabitu Babatunde, et al.
Publicado: (2019)

Molecular design of antioxidant lubricating oil additives via QSPR and analysis dynamic simulation method
por: Abdulfatai, Usman, et al.
Publicado: (2019)

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2
por: Umar, Abdullahi Bello, et al.
Publicado: (2020)

Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a Pf-DHODH protein target
por: Ibrahim, Zakari Ya’u, et al.
Publicado: (2022)

Obstructing Salmonella typhi's virulence in eukaryotic cells through design of its SipB protein antagonists
por: Ameji, John P., et al.
Publicado: (2022)

QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds
por: Mahmud, Aliyu Wappah, et al.
Publicado: (2020)

Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents
por: Isyaku, Yusuf, et al.
Publicado: (2020)

In silico studies of piperazine derivatives as potent anti-proliferative agents against PC-3 prostate cancer cell lines
por: Ikwu, Fabian A., et al.
Publicado: (2020)

Theoretical QSAR modelling and molecular docking studies of some 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzyme inhibitors potentially used as herbicides
por: Tukur, Saidu, et al.
Publicado: (2019)

A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
por: Adeniji, Shola Elijah, et al.
Publicado: (2019)

Application of QSAR Method in the Design of Enhanced Antimalarial Derivatives of Azetidine-2-carbonitriles, their Molecular Docking, Drug-likeness, and SwissADME Properties
por: Ibrahim, Zakari Ya’u, et al.
Publicado: (2021)

Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of Plasmodium falciparum
por: Ibrahim, Zakari Ya'u, et al.
Publicado: (2021)

Quantitative structure-activity relationship and molecular docking studies of a series of quinazolinonyl analogues as inhibitors of gamma amino butyric acid aminotransferase
por: Abdulfatai, Usman, et al.
Publicado: (2017)

QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate
por: Edache, Emmanuel Israel, et al.
Publicado: (2022)

Theoretical design of novel antimalarial agents against P. falciparum strain, Dd(2) through the QSAR modeling of synthesized 2′-substituted triclosan derivatives
por: Ibrahim, Zakari Ya'u, et al.
Publicado: (2020)

Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
por: Shallangwa, Gideon Adamu, et al.
Publicado: (2021)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodiumfalciparum
por: Ibrahim, Zakari Y., et al.
Publicado: (2023)

In silico prediction of nuclear receptor binding to polychlorinated dibenzofurans and its implication on endocrine disruption in humans and wildlife
por: Akinola, Lukman K., et al.
Publicado: (2021)

QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line
por: Lawal, Hadiza Abdulrahman, et al.
Publicado: (2020)

Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies
por: Ibrahim, Muktar Musa, et al.
Publicado: (2023)

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease
por: Edache, Emmanuel Israel, et al.
Publicado: (2023)

In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor
por: Nulamuga, Benson, et al.
Publicado: (2022)

New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties
por: Umar, Abdullahi B., et al.
Publicado: (2023)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018)

Mechanism and rate constant of proline-catalysed asymmetric aldol reaction of acetone and p-nitrobenzaldehyde in solution medium: Density-functional theory computation
por: Tafida, Usman I., et al.
Publicado: (2018)

Free radical scavenging mechanism of 1,3,4-oxadiazole derivatives: thermodynamics of O–H and N–H bond cleavage
por: Alisi, Ikechukwu Ogadimma, et al.
Publicado: (2020)

Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents
por: Adeniji, Shola Elijah, et al.
Publicado: (2020)

Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinaseinhibitors
por: Umar, Abdullahi B., et al.
Publicado: (2023)

Evaluation of the antioxidant properties of curcumin derivatives by genetic function algorithm
por: Alisi, Ikechukwu Ogadimma, et al.
Publicado: (2018)

Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities
por: Jafari, Elham, et al.
Publicado: (2016)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
por: Uzairu, Sani Muhammad, et al.
Publicado: (2022)

Synthesis and Evaluation of 2,4-Disubstituted Quinazoline Derivatives with Potent Anti-Angiogenesis Activities
por: Yu, Guangjin, et al.
Publicado: (2014)

The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
por: Newton, Rebecca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_55vngee3sl9gp9q2k0clqpaj8a